Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan

被引:8
作者
Dousa, Michal [1 ]
Gibala, Petr [1 ]
Radl, Stanislav [1 ]
Klecan, Ondrej [1 ]
Mandelova, Zuzana [1 ]
Brichac, Jiri [1 ]
Pekarek, Tomas [1 ]
机构
[1] Zentiva, As Praha, Prague 10237 10, Czech Republic
关键词
Zolmitriptan; Impurity; Identification; Preparation; PERFORMANCE LIQUID-CHROMATOGRAPHY; EFFICIENT SYNTHESIS; HUMAN PLASMA;
D O I
10.1016/j.jpba.2011.08.043
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A new impurity was detected and determined using gradient ion-pair UHPLC method with UV detection in zolmitriptan (ZOL). Using MS, NMR and IR study the impurity was identified as (4S,4'S)-4,4'-(2,2'-(4-(dimethylamino)butane-1,1-diyl)bis(3-(2-(dimethylamino) ethyl)-1H-indole-5,2-diyl))bis(methylene)di(oxazolidin-2-one) (ZOL-dimer). The standard of ZOL-dimer was consequently prepared via organic synthesis followed by semipreparative HPLC purification. The UHPLC method was optimized in order to selectively detect and quantify other known and unknown process-related impurities and degradation products of ZOL as well. The presented method which was validated with respect to linearity, accuracy, precision and selectivity has an advantage of a very quick UHPLC chromatographic separation (less than 7 min including re-equilibration time) and therefore is highly suitable for routine analysis of related substances and stability studies of ZOL. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 18 条
[1]  
[Anonymous], 2009, EUR PHARM, P4407
[2]  
[Anonymous], 2006, ICH HARM TRIP GUID Q
[3]  
[Anonymous], 2005, INT C HARM VAL AN PR
[4]  
Bandgar BP, 2004, MONATSH CHEM, V135, P1265, DOI 10.1007/s00706-004-0206-6
[5]   A facile and efficient synthesis of 2,2-bis(3′/2′-indolyl)ethylamines and three bisindolic natural products [J].
Chakrabarty, M ;
Ghosh, N ;
Basak, R ;
Harigaya, Y .
SYNTHETIC COMMUNICATIONS, 2004, 34 (03) :421-434
[6]   High-performance liquid chromatographic analysis of zolmitriptan in human plasma using fluorescence detection [J].
Chen, J ;
Jiang, XG ;
Jiang, WM ;
Mei, N ;
Gao, XL ;
Zhang, QZ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (03) :639-645
[7]   Simultaneous measurement of zolmitriptan and its major metabolites N-desmethylzolmitriptan and zolmitriptan N-oxide in human plasma by high-performance liquid chromatography with coulometric detection [J].
Clement, EM ;
Franklin, M .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 766 (02) :339-343
[8]   BIS-(2-INDOLY)METHANES .8. SYNTHESIS AND NMR-SPECTROSCOPIC INVESTIGATION OF BIS-(METHYL-2-INDOLYL)ARYLMETHANES [J].
DITTMANN, K ;
PINDUR, U .
ARCHIV DER PHARMAZIE, 1985, 318 (04) :340-350
[9]   The clinical pharmacokinetics of zolmitriptan [J].
Dixon, R ;
Warrander, A .
CEPHALALGIA, 1997, 17 :15-20
[10]   5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs [J].
Johnson, KW ;
Schaus, JM ;
Durkin, MM ;
Audia, JE ;
Kaldor, SW ;
Flaugh, ME ;
Adham, N ;
Zgombick, JM ;
Cohen, ML ;
Branchek, TA ;
Phebus, LA .
NEUROREPORT, 1997, 8 (9-10) :2237-2240